✦ LIBER ✦

Use of on-Treatment HBsAg Level and HBeAg Index Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

✍ Scribed by Phisalprapa, Pochamana ;Charatcharoenwitthaya, Phunchai ;Chainuvati, Siwaporn P. ;Nimanong, Supot ;Pausawasdi, Nonthalee ;Prachayakul, Varayu ;Pongprasobchai, Supot ;Leelakusolvong, Somchai ;Manatsathit, Sataporn ;Kachintorn, Udom ;Tanwandee, Tawesak

Book ID: 121890351
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 570 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63862-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

On-Treatment HBsAg Level Can Early Predi

On-Treatment HBsAg Level Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Negative Patients Treated With Peginterferon ALPHA-2A

✍ Phisalprapa, Pochamana ;Charatcharoenwitthaya, Phunchai ;Chainuvati, Siwaporn P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

On-treatment serum HBsAg level is predic

On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients

✍ Wei Cai; Qing Xie; Baoyan An; Hui Wang; Xiaqiu Zhou; Guomin Zhao; Qing Guo; Ruiy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 397 KB

P407 HBeAg INDEX AND HBVDNA REDUCTION CA

P407 HBeAg INDEX AND HBVDNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP

✍ Phisalprapa, P.; Charatcharoenwitthaya, P.; Chainuwatti, S.; Chotiyaputta, W.; N 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 78 KB

917 ON-TREATMENT MONITORING OF HBsAg LEV

917 ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B

✍ G.K.K. Lau; P. Marcellin; M. Brunetto; T. Piratvisuth; H.-P. Kapprell; D. Messin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Early on-treatment prediction of respons

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

✍ Vincent Rijckborst; Bettina E. Hansen; Yilmaz Cakaloglu; Peter Ferenci; Fehmi Ta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Ferenci is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche. Dr. Janssen is a consultant for and received grants from Roche, Bristol-Myers Squibb, Schering-Plough, Novartis, and Gilead. Dr. Flisiak received grants from Roche.

Prediction of response to entecavir ther

Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels

✍ J. W. Shin; S. W. Jung; B. R. Park; C. J. Kim; J. B. Eum; B. G. Kim; I. D. Jeong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB